Status:
COMPLETED
Yoga for Psychological Distress in Gynecologic, Gastrointestinal, or Thoracic Cancer
Lead Sponsor:
University of Florida
Conditions:
Gynecologic Cancer
Adjustment
Eligibility:
FEMALE
18-90 years
Phase:
NA
Brief Summary
This study will test the feasibility and acceptability of a yoga program for women with gynecologic, gastrointestinal (GI), or thoracic malignancies. This study will pilot an integrative yoga interven...
Detailed Description
Gynecologic cancers are malignancies of the female reproductive tract that affect over 70,000 women per year. Treatments for gynecologic cancer often result in numerous physical and emotional side eff...
Eligibility Criteria
Inclusion
- Presence of newly diagnosed
- pathology-confirmed
- (a) gynecologic cancer (e.g., cancer of the ovaries, cervix, endometrium, fallopian tubes), any stage, or
- (b) borderline ovarian tumor, Stage II-III
- Undergoing (or have recently undergone) surgery and/or active cancer treatment (e.g., chemotherapy, radiation, a combination of these treatments and/or another form of cancer treatment)
- Able to read and write in English
Exclusion
- History of gynecologic cancer or other cancer diagnosis (excluding basal cell or squamous cell carcinomas of the skin)
- Current, severe, uncontrolled psychopathology (e.g., symptomatic Bipolar Disorder with a manic or depressive episode in the last six months, psychotic symptoms or disorder, or documented personality disorder)
- History of dementia or other neurocognitive disorder that may interfere with participants' ability to adhere to study procedures
- Poor performance status as determined by a Karnofsky Status Score \< 60,
- For those with any childbearing potential (i.e., 18 - 62 years of age, have intact reproductive organs, and/or have not yet started chemotherapy or radiation therapy): self-reported current pregnancy, possible pregnancy, or efforts to become pregnant
- History of regular or immersive yoga practice in the last five years defined as attending at least once weekly yoga classes for at least 6 consecutive months at any point in the prior 5 years
Key Trial Info
Start Date :
February 5 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 14 2022
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT03385577
Start Date
February 5 2018
End Date
November 14 2022
Last Update
June 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Gainesville, Florida, United States, 32610